Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
smaller decrease » marked decrease (Expand Search), smaller areas (Expand Search), larger decrease (Expand Search)
small decrease » small increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
smaller decrease » marked decrease (Expand Search), smaller areas (Expand Search), larger decrease (Expand Search)
small decrease » small increased (Expand Search)
-
441
-
442
-
443
Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025)
Published 2025“…Singers produced significantly smaller mean smallest changes of both <i>F</i>0 and intensity than nonsingers.…”
-
444
-
445
Cytokine production in mice transplanted with feces from people with intestinal protists.
Published 2024Subjects: -
446
-
447
-
448
-
449
-
450
NK cell frequencies in the colon and spleen of mice with FMT from people with intestinal protists.
Published 2024Subjects: -
451
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
452
-
453
-
454
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
455
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
456
-
457
-
458
-
459
-
460